112 related articles for article (PubMed ID: 17007940)
1. A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis.
Hassen GW; Feliberti J; Kesner L; Stracher A; Mokhtarian F
J Neuroimmunol; 2006 Nov; 180(1-2):135-46. PubMed ID: 17007940
[TBL] [Abstract][Full Text] [Related]
2. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
Guo X; Nakamura K; Kohyama K; Harada C; Behanna HA; Watterson DM; Matsumoto Y; Harada T
Neurosci Res; 2007 Dec; 59(4):457-66. PubMed ID: 17920148
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Chen X; Hu X; Zou Y; Pi R; Liu M; Wang T; Zheng X; Liu M; Lin M; Liu P; Tao L
J Neuroimmunol; 2009 May; 210(1-2):22-9. PubMed ID: 19344957
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
6. Murine complement C4 is not required for experimental autoimmune encephalomyelitis.
Boos LA; Szalai AJ; Barnum SR
Glia; 2005 Jan; 49(1):158-60. PubMed ID: 15390104
[TBL] [Abstract][Full Text] [Related]
7. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
Sun X; Minohara M; Kikuchi H; Ishizu T; Tanaka M; Piao H; Osoegawa M; Ohyagi Y; Shimokawa H; Kira J
J Neuroimmunol; 2006 Nov; 180(1-2):126-34. PubMed ID: 16996142
[TBL] [Abstract][Full Text] [Related]
8. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
[TBL] [Abstract][Full Text] [Related]
9. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
[TBL] [Abstract][Full Text] [Related]
11. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies.
Peiris M; Monteith GR; Roberts-Thomson SJ; Cabot PJ
J Neurosci Methods; 2007 Jul; 163(2):245-54. PubMed ID: 17477973
[TBL] [Abstract][Full Text] [Related]
12. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
Quintana A; Müller M; Frausto RF; Ramos R; Getts DR; Sanz E; Hofer MJ; Krauthausen M; King NJ; Hidalgo J; Campbell IL
J Immunol; 2009 Aug; 183(3):2079-88. PubMed ID: 19597000
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
[TBL] [Abstract][Full Text] [Related]
14. Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis.
Archambault AS; Sim J; McCandless EE; Klein RS; Russell JH
J Neuroimmunol; 2006 Dec; 181(1-2):122-32. PubMed ID: 17030428
[TBL] [Abstract][Full Text] [Related]
15. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
16. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
Wang P; Wang ZW; Lin FH; Han Z; Hou ST; Zheng RY
Biochem Biophys Res Commun; 2011 Mar; 406(1):152-7. PubMed ID: 21303658
[TBL] [Abstract][Full Text] [Related]
17. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
18. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
[TBL] [Abstract][Full Text] [Related]
19. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
